Vimarsana
Biggest News Aggregation in the World

Page 10 - Cost Effectiveness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cost Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cost Effectiveness Today - Breaking & Trending Today

Intensive Surveillance Cost-Effective in Stage II, III CRC - Vimarsana News

Intensive Surveillance Cost-Effective in Stage II, III CRC

Intensive surveillance after resection on patients with colorectal cancer (CRC) was less cost-effective in stage I but most cost-effective in stage II and III disease.

Source: ajmc.com
Viral Vectors in Gene Therapy - Vimarsana News

Viral Vectors in Gene Therapy

Emma Ciafaloni, MD, FAAN, describes the key differences among viral vectors used in gene therapy, highlighting their applications and strengths in targeting specific diseases.

Source: ajmc.com
Overview of Gene Therapy Approaches and Impacts - Vimarsana News

Overview of Gene Therapy Approaches and Impacts

Experts delve into the fundamentals of gene therapy, covering in vivo and ex vivo methods, and explore cellular function targets for effective treatment of a disease.

Source: ajmc.com
Key Factors in Gene Vector Selection - Vimarsana News

Key Factors in Gene Vector Selection

Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression.

Source: ajmc.com
Premia Spine's TOPS device more cost-effective than TLIF: Study - Vimarsana News

Premia Spine's TOPS device more cost-effective than TLIF: Study

The TOPS device, for lumbar facet arthroplasty, is more cost-effective compared to a transforaminal lumbar interbody fusion when addressing degenerative spondyl